{"id":131568,"date":"2023-06-07T07:23:44","date_gmt":"2023-06-07T07:23:44","guid":{"rendered":"https:\/\/ccs.ca\/?post_type=guideline&p=131568"},"modified":"2023-06-07T07:57:29","modified_gmt":"2023-06-07T07:57:29","slug":"chapter-1-driving-coronary-heart-disease","status":"publish","type":"guideline","link":"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/","title":{"rendered":"1. Driving: Coronary Heart Disease"},"content":{"rendered":"\n

Acute Coronary Syndromes<\/h2>\n\n\n
\n
\n
\n <\/i>\n <\/div>\n
\n

ST elevation MI<\/p>

    \n
  • Private driving is permitted beginning 1 month after discharge.<\/li>\n
  • Commercial driving is permitted beginning 3 months after discharge.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n\n\n
    \n
    \n
    \n <\/i>\n <\/div>\n
    \n

    Non-ST elevation MI with significant LV damage*<\/p>

      \n
    • Private driving is permitted beginning 1 month after discharge.<\/li>\n
    • Commercial driving is permitted beginning 3 months after discharge.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n\n\n
      \n
      \n
      \n <\/i>\n <\/div>\n
      \n

      Non-ST elevation MI with minor LV damage* (PCI perfomed)<\/p>

        \n
      • Private driving is permitted beginning 48 hours after PCI.<\/li>\n
      • Commercial driving is permitted beginning 7 days after PCI.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n\n\n
        \n
        \n
        \n <\/i>\n <\/div>\n
        \n

        Non-ST elevation MI with minor LV damage* (PCI not perfomed)<\/p>

          \n
        • Private driving is permitted beginning 7 days after discharge.<\/li>\n
        • Commercial driving is permitted beginning 30 days after discharge.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n\n\n
          \n
          \n
          \n <\/i>\n <\/div>\n
          \n

          Acute coronary syndrome without MI (unstable angina) (PCI perfomed)<\/p>

            \n
          • Private driving is permitted beginning 48 hours after PCI.<\/li>\n
          • Commercial driving is permitted beginning 7 days after PCI.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n\n\n
            \n
            \n
            \n <\/i>\n <\/div>\n
            \n

            Acute coronary syndrome without MI (unstable angina) (PCI not perfomed)<\/p>

              \n
            • Private driving is permitted beginning 7 days after discharge.<\/li>\n
            • Commercial driving is permitted beginning 30 days after discharge.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n\n\n\n

              *Minor left ventricle (LV) damage is classified as a myocardial infarction (MI) defined only by elevated troponin with or without electrocardiogram changes and in absence of a new wall motion abnormality. Significant LV damage is defined as any MI that is not classified as minor. Notwithstanding any of the foregoing recommendations, angiographic demonstration of 50% or greater reduction in the diameter of the left main coronary artery should disqualify the patient from commercial driving, and 70% or greater should disqualify the patient for private driving, unless treated with revascularization.<\/p>\n\n\n\n

              Stable Coronary Artery Disease<\/h2>\n\n\n
              \n
              \n
              \n <\/i>\n <\/div>\n
              \n

              Stable Angina<\/p>

                \n
              • Private driving is permitted with no restriction.<\/li>\n
              • Commercial driving is permitted with no restriction.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n\n\n
                \n
                \n
                \n <\/i>\n <\/div>\n
                \n

                Asymptomatic coronary artery disease<\/p>

                  \n
                • Private driving is permitted with no restriction.<\/li>\n
                • Commercial driving is permitted with no restriction.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n\n\n
                  \n
                  \n
                  \n <\/i>\n <\/div>\n
                  \n

                  PCI<\/p>

                    \n
                  • Private driving is permitted beginning 48 hours after PCI.<\/li>\n
                  • Commercial driving is permitted 48 hours after PCI.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n\n\n\n

                    Notwithstanding any of the foregoing recommendations, angiographic demonstration of 50% or greater reduction in the diameter of the left main coronary artery should disqualify the patient from commercial driving, and 70% or greater should disqualify the patient for private driving, unless treated with revascularization.<\/p>\n\n\n\n

                    Cardiac Surgery for Coronary Artery Disease<\/h2>\n\n\n
                    \n
                    \n
                    \n <\/i>\n <\/div>\n
                    \n

                    CABG surgery<\/p>

                      \n
                    • Private driving is permitted beginning 1 month after discharge.<\/li>\n
                    • Commercial driving is permitted beginning 3 months after discharge.<\/li>\n<\/ul>\n <\/div>\n <\/div>\n<\/div>\n","protected":false},"featured_media":0,"parent":131566,"menu_order":0,"template":"guideline-chapter.php","topic":[],"resource_type":[],"acf":[],"yoast_head":"\n1. Driving: Coronary Heart Disease - Canadian Cardiovascular Society<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"1. Driving: Coronary Heart Disease - Canadian Cardiovascular Society\" \/>\n<meta property=\"og:description\" content=\"Acute Coronary Syndromes *Minor left ventricle (LV) damage is classified as a myocardial infarction (MI) defined only by elevated troponin with or without electrocardiogram changes and in absence of a new wall motion abnormality. Significant LV damage is defined as any MI that is not classified as minor. Notwithstanding any of the foregoing recommendations, angiographic […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/\" \/>\n<meta property=\"og:site_name\" content=\"Canadian Cardiovascular Society\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SCC.CCS.ca\/\" \/>\n<meta property=\"article:modified_time\" content=\"2023-06-07T07:57:29+00:00\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:site\" content=\"@SCC_CCS\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/\",\"url\":\"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/\",\"name\":\"1. Driving: Coronary Heart Disease - Canadian Cardiovascular Society\",\"isPartOf\":{\"@id\":\"https:\/\/ccs.ca\/#website\"},\"datePublished\":\"2023-06-07T07:23:44+00:00\",\"dateModified\":\"2023-06-07T07:57:29+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Drive & Fly (2003)\",\"item\":\"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"1. Driving: Coronary Heart Disease\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/ccs.ca\/#website\",\"url\":\"https:\/\/ccs.ca\/\",\"name\":\"Canadian Cardiovascular Society\",\"description\":\"Strong heart teams in a heart-healthy Canada.\",\"publisher\":{\"@id\":\"https:\/\/ccs.ca\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/ccs.ca\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/ccs.ca\/#organization\",\"name\":\"Canadian Cardiovascular Society\",\"url\":\"https:\/\/ccs.ca\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/ccs.ca\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png\",\"contentUrl\":\"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png\",\"width\":699,\"height\":250,\"caption\":\"Canadian Cardiovascular Society\"},\"image\":{\"@id\":\"https:\/\/ccs.ca\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/SCC.CCS.ca\/\",\"https:\/\/x.com\/SCC_CCS\",\"https:\/\/ca.linkedin.com\/company\/canadian-cardiovascular-society\"]}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"1. Driving: Coronary Heart Disease - Canadian Cardiovascular Society","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/","og_locale":"en_US","og_type":"article","og_title":"1. Driving: Coronary Heart Disease - Canadian Cardiovascular Society","og_description":"Acute Coronary Syndromes *Minor left ventricle (LV) damage is classified as a myocardial infarction (MI) defined only by elevated troponin with or without electrocardiogram changes and in absence of a new wall motion abnormality. Significant LV damage is defined as any MI that is not classified as minor. Notwithstanding any of the foregoing recommendations, angiographic […]","og_url":"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/","og_site_name":"Canadian Cardiovascular Society","article_publisher":"https:\/\/www.facebook.com\/SCC.CCS.ca\/","article_modified_time":"2023-06-07T07:57:29+00:00","twitter_card":"summary_large_image","twitter_site":"@SCC_CCS","twitter_misc":{"Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/","url":"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/","name":"1. Driving: Coronary Heart Disease - Canadian Cardiovascular Society","isPartOf":{"@id":"https:\/\/ccs.ca\/#website"},"datePublished":"2023-06-07T07:23:44+00:00","dateModified":"2023-06-07T07:57:29+00:00","breadcrumb":{"@id":"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/chapter-1-driving-coronary-heart-disease\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Drive & Fly (2003)","item":"https:\/\/ccs.ca\/guideline\/drive-and-fly-2003\/"},{"@type":"ListItem","position":2,"name":"1. Driving: Coronary Heart Disease"}]},{"@type":"WebSite","@id":"https:\/\/ccs.ca\/#website","url":"https:\/\/ccs.ca\/","name":"Canadian Cardiovascular Society","description":"Strong heart teams in a heart-healthy Canada.","publisher":{"@id":"https:\/\/ccs.ca\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ccs.ca\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/ccs.ca\/#organization","name":"Canadian Cardiovascular Society","url":"https:\/\/ccs.ca\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/ccs.ca\/#\/schema\/logo\/image\/","url":"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png","contentUrl":"https:\/\/ccs.ca\/wp-content\/uploads\/2022\/12\/cropped-CCS-3line-ENG-Trimmed.png","width":699,"height":250,"caption":"Canadian Cardiovascular Society"},"image":{"@id":"https:\/\/ccs.ca\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SCC.CCS.ca\/","https:\/\/x.com\/SCC_CCS","https:\/\/ca.linkedin.com\/company\/canadian-cardiovascular-society"]}]}},"_links":{"self":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/guideline\/131568"}],"collection":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/guideline"}],"about":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/types\/guideline"}],"version-history":[{"count":7,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/guideline\/131568\/revisions"}],"predecessor-version":[{"id":131577,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/guideline\/131568\/revisions\/131577"}],"up":[{"embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/guideline\/131566"}],"wp:attachment":[{"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/media?parent=131568"}],"wp:term":[{"taxonomy":"topic","embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/topic?post=131568"},{"taxonomy":"resource_type","embeddable":true,"href":"https:\/\/ccs.ca\/wp-json\/wp\/v2\/resource_type?post=131568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}